Industry Research Reports

Home > Reports > Medical Care > Peripheral Parenteral Nutrition (PPN) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Peripheral Parenteral Nutrition (PPN) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-11

Pages: 113 Pages

Report ld: 2639221

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Peripheral Parenteral Nutrition (PPN) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Peripheral Parenteral Nutrition (PPN) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Peripheral Parenteral Nutrition (PPN) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Peripheral Parenteral Nutrition (PPN) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Peripheral Parenteral Nutrition (PPN) include Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira) and Ostuka Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Peripheral Parenteral Nutrition (PPN), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Peripheral Parenteral Nutrition (PPN) by region & country, by Type, and by Application.

The Peripheral Parenteral Nutrition (PPN) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Parenteral Nutrition (PPN).

Market Segmentation

Report Metric
Details
Report Title
Peripheral Parenteral Nutrition (PPN) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Peripheral Parenteral Nutrition (PPN) Companies Covered
Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, Laboratorios Biogalenic, Laboratorios Finlay, Grifols International, Fresenius Kabi, Sichuan Kelun Pharmaceutical
Global Peripheral Parenteral Nutrition (PPN) Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Peripheral Parenteral Nutrition (PPN) Market, Segment by Type
Carbohydrates

Parenteral Lipid Emulsion

Single Dose Amino Acid Solution

Trace Elements

Vitamins and Minerals
Global Peripheral Parenteral Nutrition (PPN) Market, Segment by Application
Hospital

Home
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Peripheral Parenteral Nutrition (PPN) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Peripheral Parenteral Nutrition (PPN) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Peripheral Parenteral Nutrition (PPN) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Peripheral Parenteral Nutrition (PPN) Product Introduction
    1.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Forecast
    1.3 Peripheral Parenteral Nutrition (PPN) Market Trends & Drivers
        1.3.1 Peripheral Parenteral Nutrition (PPN) Industry Trends
        1.3.2 Peripheral Parenteral Nutrition (PPN) Market Drivers & Opportunity
        1.3.3 Peripheral Parenteral Nutrition (PPN) Market Challenges
        1.3.4 Peripheral Parenteral Nutrition (PPN) Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Peripheral Parenteral Nutrition (PPN) Players Revenue Ranking (2023)
    2.2 Global Peripheral Parenteral Nutrition (PPN) Revenue by Company (2019-2024)
    2.3 Key Companies Peripheral Parenteral Nutrition (PPN) Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Peripheral Parenteral Nutrition (PPN) Product Offered
    2.5 Key Companies Time to Begin Mass Production of Peripheral Parenteral Nutrition (PPN)
    2.6 Peripheral Parenteral Nutrition (PPN) Market Competitive Analysis
        2.6.1 Peripheral Parenteral Nutrition (PPN) Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Peripheral Parenteral Nutrition (PPN) Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Carbohydrates
        3.1.2 Parenteral Lipid Emulsion
        3.1.3 Single Dose Amino Acid Solution
        3.1.4 Trace Elements
        3.1.5 Vitamins and Minerals
    3.2 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Type
        3.2.1 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Peripheral Parenteral Nutrition (PPN) Sales Value, by Type (2019-2030)
        3.2.3 Global Peripheral Parenteral Nutrition (PPN) Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Home
    4.2 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Application
        4.2.1 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Peripheral Parenteral Nutrition (PPN) Sales Value, by Application (2019-2030)
        4.2.3 Global Peripheral Parenteral Nutrition (PPN) Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region
        5.1.1 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (2019-2024)
        5.1.3 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (2025-2030)
        5.1.4 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
        5.2.2 North America Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
        5.3.2 Europe Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
        5.4.2 Asia Pacific Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
        5.5.2 South America Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
        5.6.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Peripheral Parenteral Nutrition (PPN) Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Peripheral Parenteral Nutrition (PPN) Sales Value
    6.3 United States
        6.3.1 United States Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
        6.3.2 United States Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
        6.4.2 Europe Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
        6.5.2 China Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
        6.6.2 Japan Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
        6.7.2 South Korea Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
        6.8.2 Southeast Asia Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Peripheral Parenteral Nutrition (PPN) Sales Value, 2019-2030
        6.9.2 India Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Peripheral Parenteral Nutrition (PPN) Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Eurofarma
        7.1.1 Eurofarma Profile
        7.1.2 Eurofarma Main Business
        7.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.1.4 Eurofarma Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.1.5 Eurofarma Recent Developments
    7.2 Corporacion De Laboratorios Farmaceuticos
        7.2.1 Corporacion De Laboratorios Farmaceuticos Profile
        7.2.2 Corporacion De Laboratorios Farmaceuticos Main Business
        7.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.2.4 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.2.5 Corporacion De Laboratorios Farmaceuticos Recent Developments
    7.3 Baxter International Inc.
        7.3.1 Baxter International Inc. Profile
        7.3.2 Baxter International Inc. Main Business
        7.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.3.4 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.3.5 Kelun Pharma Recent Developments
    7.4 Kelun Pharma
        7.4.1 Kelun Pharma Profile
        7.4.2 Kelun Pharma Main Business
        7.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.4.4 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.4.5 Kelun Pharma Recent Developments
    7.5 B. Braun
        7.5.1 B. Braun Profile
        7.5.2 B. Braun Main Business
        7.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.5.4 B. Braun Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.5.5 B. Braun Recent Developments
    7.6 Fresenius
        7.6.1 Fresenius Profile
        7.6.2 Fresenius Main Business
        7.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.6.4 Fresenius Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.6.5 Fresenius Recent Developments
    7.7 Teva Pharmaceutical Industries
        7.7.1 Teva Pharmaceutical Industries Profile
        7.7.2 Teva Pharmaceutical Industries Main Business
        7.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.7.4 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.7.5 Teva Pharmaceutical Industries Recent Developments
    7.8 Pfizer (Hospira)
        7.8.1 Pfizer (Hospira) Profile
        7.8.2 Pfizer (Hospira) Main Business
        7.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.8.4 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.8.5 Pfizer (Hospira) Recent Developments
    7.9 Ostuka Pharmaceutical
        7.9.1 Ostuka Pharmaceutical Profile
        7.9.2 Ostuka Pharmaceutical Main Business
        7.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.9.4 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.9.5 Ostuka Pharmaceutical Recent Developments
    7.10 Laboratorios Biogalenic
        7.10.1 Laboratorios Biogalenic Profile
        7.10.2 Laboratorios Biogalenic Main Business
        7.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.10.4 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.10.5 Laboratorios Biogalenic Recent Developments
    7.11 Laboratorios Finlay
        7.11.1 Laboratorios Finlay Profile
        7.11.2 Laboratorios Finlay Main Business
        7.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.11.4 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.11.5 Laboratorios Finlay Recent Developments
    7.12 Grifols International
        7.12.1 Grifols International Profile
        7.12.2 Grifols International Main Business
        7.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.12.4 Grifols International Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.12.5 Grifols International Recent Developments
    7.13 Fresenius Kabi
        7.13.1 Fresenius Kabi Profile
        7.13.2 Fresenius Kabi Main Business
        7.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.13.4 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.13.5 Fresenius Kabi Recent Developments
    7.14 Sichuan Kelun Pharmaceutical
        7.14.1 Sichuan Kelun Pharmaceutical Profile
        7.14.2 Sichuan Kelun Pharmaceutical Main Business
        7.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
        7.14.4 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue (US$ Million) & (2019-2024)
        7.14.5 Sichuan Kelun Pharmaceutical Recent Developments

 8 Industry Chain Analysis
    8.1 Peripheral Parenteral Nutrition (PPN) Industrial Chain
    8.2 Peripheral Parenteral Nutrition (PPN) Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Peripheral Parenteral Nutrition (PPN) Sales Model
        8.5.2 Sales Channel
        8.5.3 Peripheral Parenteral Nutrition (PPN) Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Peripheral Parenteral Nutrition (PPN) Market Trends
    Table 2. Peripheral Parenteral Nutrition (PPN) Market Drivers & Opportunity
    Table 3. Peripheral Parenteral Nutrition (PPN) Market Challenges
    Table 4. Peripheral Parenteral Nutrition (PPN) Market Restraints
    Table 5. Global Peripheral Parenteral Nutrition (PPN) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Peripheral Parenteral Nutrition (PPN) Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Peripheral Parenteral Nutrition (PPN) Product Type
    Table 9. Key Companies Time to Begin Mass Production of Peripheral Parenteral Nutrition (PPN)
    Table 10. Global Peripheral Parenteral Nutrition (PPN) Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Peripheral Parenteral Nutrition (PPN) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Peripheral Parenteral Nutrition (PPN) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Peripheral Parenteral Nutrition (PPN) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Peripheral Parenteral Nutrition (PPN) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (2019-2024) & (%)
    Table 27. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Peripheral Parenteral Nutrition (PPN) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Peripheral Parenteral Nutrition (PPN) Sales Value, (2025-2030) & (US$ Million)
    Table 31. Eurofarma Basic Information List
    Table 32. Eurofarma Description and Business Overview
    Table 33. Eurofarma Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Eurofarma (2019-2024)
    Table 35. Eurofarma Recent Developments
    Table 36. Corporacion De Laboratorios Farmaceuticos Basic Information List
    Table 37. Corporacion De Laboratorios Farmaceuticos Description and Business Overview
    Table 38. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Corporacion De Laboratorios Farmaceuticos (2019-2024)
    Table 40. Corporacion De Laboratorios Farmaceuticos Recent Developments
    Table 41. Baxter International Inc. Basic Information List
    Table 42. Baxter International Inc. Description and Business Overview
    Table 43. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Baxter International Inc. (2019-2024)
    Table 45. Baxter International Inc. Recent Developments
    Table 46. Kelun Pharma Basic Information List
    Table 47. Kelun Pharma Description and Business Overview
    Table 48. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Kelun Pharma (2019-2024)
    Table 50. Kelun Pharma Recent Developments
    Table 51. B. Braun Basic Information List
    Table 52. B. Braun Description and Business Overview
    Table 53. B. Braun Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of B. Braun (2019-2024)
    Table 55. B. Braun Recent Developments
    Table 56. Fresenius Basic Information List
    Table 57. Fresenius Description and Business Overview
    Table 58. Fresenius Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Fresenius (2019-2024)
    Table 60. Fresenius Recent Developments
    Table 61. Teva Pharmaceutical Industries Basic Information List
    Table 62. Teva Pharmaceutical Industries Description and Business Overview
    Table 63. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Teva Pharmaceutical Industries (2019-2024)
    Table 65. Teva Pharmaceutical Industries Recent Developments
    Table 66. Pfizer (Hospira) Basic Information List
    Table 67. Pfizer (Hospira) Description and Business Overview
    Table 68. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Pfizer (Hospira) (2019-2024)
    Table 70. Pfizer (Hospira) Recent Developments
    Table 71. Ostuka Pharmaceutical Basic Information List
    Table 72. Ostuka Pharmaceutical Description and Business Overview
    Table 73. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Ostuka Pharmaceutical (2019-2024)
    Table 75. Ostuka Pharmaceutical Recent Developments
    Table 76. Laboratorios Biogalenic Basic Information List
    Table 77. Laboratorios Biogalenic Description and Business Overview
    Table 78. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Laboratorios Biogalenic (2019-2024)
    Table 80. Laboratorios Biogalenic Recent Developments
    Table 81. Laboratorios Finlay Basic Information List
    Table 82. Laboratorios Finlay Description and Business Overview
    Table 83. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Laboratorios Finlay (2019-2024)
    Table 85. Laboratorios Finlay Recent Developments
    Table 86. Grifols International Basic Information List
    Table 87. Grifols International Description and Business Overview
    Table 88. Grifols International Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Grifols International (2019-2024)
    Table 90. Grifols International Recent Developments
    Table 91. Fresenius Kabi Basic Information List
    Table 92. Fresenius Kabi Description and Business Overview
    Table 93. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Fresenius Kabi (2019-2024)
    Table 95. Fresenius Kabi Recent Developments
    Table 96. Sichuan Kelun Pharmaceutical Basic Information List
    Table 97. Sichuan Kelun Pharmaceutical Description and Business Overview
    Table 98. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Peripheral Parenteral Nutrition (PPN) Business of Sichuan Kelun Pharmaceutical (2019-2024)
    Table 100. Sichuan Kelun Pharmaceutical Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. Peripheral Parenteral Nutrition (PPN) Downstream Customers
    Table 104. Peripheral Parenteral Nutrition (PPN) Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Peripheral Parenteral Nutrition (PPN) Product Picture
    Figure 2. Global Peripheral Parenteral Nutrition (PPN) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Peripheral Parenteral Nutrition (PPN) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Peripheral Parenteral Nutrition (PPN) Report Years Considered
    Figure 5. Global Peripheral Parenteral Nutrition (PPN) Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Peripheral Parenteral Nutrition (PPN) Revenue in 2023
    Figure 7. Peripheral Parenteral Nutrition (PPN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Carbohydrates Picture
    Figure 9. Parenteral Lipid Emulsion Picture
    Figure 10. Single Dose Amino Acid Solution Picture
    Figure 11. Trace Elements Picture
    Figure 12. Vitamins and Minerals Picture
    Figure 13. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Peripheral Parenteral Nutrition (PPN) Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Hospital
    Figure 16. Product Picture of Home
    Figure 17. Global Peripheral Parenteral Nutrition (PPN) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Peripheral Parenteral Nutrition (PPN) Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Peripheral Parenteral Nutrition (PPN) Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Peripheral Parenteral Nutrition (PPN) Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Peripheral Parenteral Nutrition (PPN) Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Peripheral Parenteral Nutrition (PPN) Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Peripheral Parenteral Nutrition (PPN) Sales Value (%), (2019-2030)
    Figure 30. United States Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Peripheral Parenteral Nutrition (PPN) Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Peripheral Parenteral Nutrition (PPN) Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Peripheral Parenteral Nutrition (PPN) Sales Value by Application (%), 2023 VS 2030
    Figure 51. Peripheral Parenteral Nutrition (PPN) Industrial Chain
    Figure 52. Peripheral Parenteral Nutrition (PPN) Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation

Description

The global market for Peripheral Parenteral Nutrition (PPN) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Peripheral Parenteral Nutrition (PPN) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Peripheral Parenteral Nutrition (PPN) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Peripheral Parenteral Nutrition (PPN) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Peripheral Parenteral Nutrition (PPN) include Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira) and Ostuka Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Peripheral Parenteral Nutrition (PPN), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Peripheral Parenteral Nutrition (PPN) by region & country, by Type, and by Application.

The Peripheral Parenteral Nutrition (PPN) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Parenteral Nutrition (PPN).

Market Segmentation